NCLH vs WHWK · P/E 16, rev $4.97B vs $202.8M cap
Norwegian Cruise Line Holdings Ltd (NCLH) versus Whitehawk Therapeutics, Inc. (WHWK) — a side-by-side from cached financials, not a winner call.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Latest reported WHWK revenue for 2026-06-30 was $0. Net income was -$38.8M. WHWK currently screens at market cap $202.8M.
NCLH currently screens at market cap $9.10B and trailing P/E 16.0. WHWK currently screens at market cap $202.8M.
Not investment advice. Open the NCLH and WHWK stock pages for the full models.
Not investment advice.